Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant gastrointestinal tumors worldwide with a dismal prognosis and high relapse rate. PDAC is considered a “cold cancer” for which immunotherapy is not effective. Therefore, to improve the prognosis for PDAC patients, it i...
Main Authors: | Hui Deng, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen, Jianchang Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Molecular and Cellular Probes |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0890850823000579 |
Similar Items
-
Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor types
by: Hong-Lu Zhou, et al.
Published: (2024-01-01) -
Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
by: Pin Chen, et al.
Published: (2023-01-01) -
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
by: Chia-Hsuan Chou, et al.
Published: (2020-08-01) -
Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival
by: Zedan Zhao, et al.
Published: (2024-03-01) -
HMGA2 overexpression activates IGF2BP2 to stabilize APLP2 via m6A modification and promote pancreatic cancer progression
by: Ke Liu, et al.
Published: (2024-03-01)